🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of ampreloxet...
Status
Terminated
Location
Banner Sun Health Research Institute
Start Date
2019-02-22
Trial ID
NCT03829657
Treatments Being Tested
An open-label study to characterize the effects of mild, moderate, and seve...
Status
Completed
Location
Theravance Biopharma Investigational Site
Start Date
2020-01-13
Trial ID
NCT04200573
Treatments Being Tested
A double-blind study to characterize the effect of ampreloxetine on cardiac...
Status
Completed
Location
Theravance Biopharma Investigational Site
Start Date
2021-01-18
Trial ID
NCT04688632
The safety and efficacy of multiple dosages of TD-9855, administered once d...
Status
Completed
Location
Florida Clinical Research Center, LLC
Start Date
2011-12
Trial ID
NCT01458340
This is a Phase 3, multi-center, randomized withdrawal study to evaluate th...
Status
Active Not Recruiting
Location
Movement Disorders Center of Arizona
Start Date
2023-06-27
Trial ID
NCT05696717
Treatments Being Tested
This study is designed to assess the effect of fluvoxamine, itraconazole an...
Status
Completed
Location
Celerion
Start Date
2018-02-28
Trial ID
NCT03432793
Treatments Being Tested
The purpose of the study is to evaluate the absorption, distribution, metab...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01924143
Treatments Being Tested
A Phase 3 study to evaluate efficacy, safety, and tolerability of ampreloxe...
Status
Completed
Location
Banner Sun Health Research Institute
Start Date
2019-01-24
Trial ID
NCT03750552
Treatments Being Tested
A Phase 3, multi-center, open-label study to evaluate the safety and tolera...
Status
Terminated
Location
Colorado Springs Neurological Associates
Start Date
2019-09-19
Trial ID
NCT04095793
Treatments Being Tested